Objectives: The latest information on the pathophysiology of acne will be discussed, including news about the microbiome as well as new treatment options.

Introduction: Up to date in acne.

Materials / method: Up to date in acne.

Results: Up to date in acne.

Conclusion: Up to date in acne.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Digital technology breakthroughs, advances in computer vision technology and artificial intelligence are meant to improve access to dermatology care to acne patients. More than ever dermatologists / PCPs are needed to manage acne patients.

Introduction: While there are 2 billion persons on earth suffering from a skin conditions, 70% (or 1.4 billion) do not have access to dermatology care. Acne is #1 skin pathology and depending the country between 60% to 83% of patients are not seen by a dermatologist / PCP. This gap is both a threat for the profession and a great opportunity for new players to enter that market.

Materials / method: Daily market intelligence (lay press and professional sources) on the following domains: dermatology, skincare, aesthetics, innovation, access to care, misinformation, artificial intelligence and digital advances. All this being captured and shared on Twitter ( https://twitter.com/ducrest ) and LinkedIN (https://www.linkedin.com/in/dominique-du-crest-2982a/recent-activity/posts/ ).

Results: Greater access to acne care is a great opportunity for all parties. Numerous digital solutions aiming at bridging it are being launched but artificial intelligence can’t search for causes of what is observed (no explanatory power). Social media has also a great role to play. Recent NICE acne guidelines are demonstrating the complexity of acne management and how doctors should act in the long term.

Conclusion: Digital advances in technology and social media should not be seen as a threat to doctors. Although some solutions will be done without doctor supervision, more than ever dermatologists / PCPs are needed to manage acne patients.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The presentation will provide a full overview on a novel FDA-cleared Nd:YAP 1,340-nm LASER wavelength for fractional nonablative skin resurfacing in the treatment of acne acne scar

Introduction: Due to its 1,340 nm exclusive non-ablative neodymium:yttrium aluminum perovskite (Nd:YAP) laser, which can penetrate up to nine times deeper than other fractional non-ablative lasers due to the higher optical conversion efficiency (other than 1,320 nm Nd:YAG) and water absorption curve, it allows the LASER wavelength to heat and shrink sebaceous glands

Materials / method: In a recent study with nine patients in the treatment of nodular-cystic acne resistant to isotretinoin,

Results: In a recent study with nine patients in the treatment of nodular-cystic acne resistant to isotretinoin, this 1,340-nm Nd:YAP LASER reduced average per-patient lesion counts from 16 to 6 – a 65% reduction.

Conclusion: In my class I will show the results of more than 10 years of experience with 1340 nm in the treatment of acne and scars - the parameters, results and tips for better answers

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability